$747 Million is the total value of Broadfin Capital, LLC's 40 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 109.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | New | ISHARES TRput | $132,536,000 | – | 800,000 | +100.0% | 17.75% | – |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO Lcall | $32,664,000 | +56.6% | 600,000 | +20.0% | 4.37% | +13.4% |
| VRAY | Buy | VIEWRAY INC | $23,524,000 | +170.3% | 5,574,366 | +85.7% | 3.15% | +95.8% |
| ALKS | Buy | ALKERMES PLC | $21,083,000 | +334.0% | 1,033,500 | +315.1% | 2.82% | +214.4% |
| QTNT | Buy | QUOTIENT LTD | $18,965,000 | +297.9% | 1,994,183 | +225.1% | 2.54% | +188.2% |
| STAA | New | STAAR SURGICAL CO | $16,253,000 | – | 462,118 | +100.0% | 2.18% | – |
| PGNX | Buy | PROGENICS PHARMACEUTICALS IN | $15,580,000 | +94.6% | 3,060,923 | +93.2% | 2.09% | +40.9% |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $15,457,000 | +546.2% | 555,600 | +401.4% | 2.07% | +368.3% |
| DERM | Buy | DERMIRA INC | $13,588,000 | +266.8% | 896,334 | +54.6% | 1.82% | +165.5% |
| LNTH | New | LANTHEUS HLDGS INC | $12,674,000 | – | 617,953 | +100.0% | 1.70% | – |
| VAPO | New | VAPOTHERM INC | $12,198,000 | – | 1,003,099 | +100.0% | 1.63% | – |
| VCEL | Buy | VERICEL CORP | $10,791,000 | +200.7% | 620,199 | +161.6% | 1.44% | +117.6% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $10,564,000 | +560.2% | 2,688,068 | +1378.2% | 1.42% | +378.0% |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $8,987,000 | – | 83,100 | +100.0% | 1.20% | – |
| RLMD | New | RELMADA THERAPEUTICS INC | $8,608,000 | – | 220,724 | +100.0% | 1.15% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $8,104,000 | – | 400,000 | +100.0% | 1.08% | – |
| XCUR | Buy | EXICURE INC | $7,744,000 | +32.4% | 2,707,851 | +17.1% | 1.04% | -4.1% |
| LMNX | New | LUMINEX CORP DEL | $4,807,000 | – | 207,553 | +100.0% | 0.64% | – |
| ALKS | New | ALKERMES PLCcall | $4,080,000 | – | 200,000 | +100.0% | 0.55% | – |
| ANAB | New | ANAPTYSBIO INC | $3,601,000 | – | 221,600 | +100.0% | 0.48% | – |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $3,568,000 | +103.9% | 1,888,039 | +16.5% | 0.48% | +47.5% |
| MYL | New | MYLAN N V | $3,015,000 | – | 150,000 | +100.0% | 0.40% | – |
| SCYX | New | SCYNEXIS INC | $1,820,000 | – | 2,000,000 | +100.0% | 0.24% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Broadfin Healthcare Master Fund Ltd #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIODELIVERY SCIENCES INTL IN | 27 | Q4 2019 | 4.8% |
| HERON THERAPEUTICS INC | 24 | Q4 2019 | 9.0% |
| LA JOLLA PHARMACEUTICAL CO | 24 | Q4 2019 | 7.7% |
| RECRO PHARMA INC | 24 | Q4 2019 | 4.1% |
| ANTARES PHARMA INC | 24 | Q3 2019 | 3.4% |
| RETROPHIN INC | 23 | Q3 2019 | 7.0% |
| ARATANA THERAPEUTICS INC | 22 | Q2 2019 | 8.1% |
| MIRATI THERAPEUTICS INC | 22 | Q1 2019 | 7.9% |
| CATALYST PHARM PARTNERS INC | 22 | Q3 2019 | 6.2% |
| ANGIODYNAMICS INC | 21 | Q3 2018 | 6.6% |
View Broadfin Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Eiger BioPharmaceuticals, Inc.Sold out | January 04, 2021 | 0 | 0.0% |
| LA JOLLA PHARMACEUTICAL COSold out | January 04, 2021 | 0 | 0.0% |
| STRATA Skin Sciences, Inc. | June 23, 2020 | 1,529,392 | 4.5% |
| Teligent, Inc.Sold out | February 25, 2020 | 0 | 0.0% |
| Neos Therapeutics, Inc.Sold out | February 14, 2020 | 0 | 0.0% |
| Aclaris Therapeutics, Inc. | February 13, 2020 | 1,888,039 | 4.6% |
| Adamas Pharmaceuticals IncSold out | February 13, 2020 | 0 | 0.0% |
| ADMA BIOLOGICS, INC.Sold out | February 13, 2020 | 0 | 0.0% |
| AVADEL PHARMACEUTICALS PLC | February 13, 2020 | 1,029,012 | 2.8% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 13, 2020 | 0 | 0.0% |
View Broadfin Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2022-03-22 |
| 4 | 2022-02-15 |
| 4 | 2022-01-31 |
| 4 | 2021-11-22 |
| 4 | 2021-11-15 |
| 4 | 2021-11-09 |
| 4 | 2021-08-10 |
| 4 | 2021-05-13 |
| SC 13G/A | 2021-01-04 |
| SC 13G/A | 2021-01-04 |
View Broadfin Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.